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Abstract 29 
Background and Aims: Lack of consensus on clinical indicators for the assessment of 30 
pediatric disease associated malnutrition (DAM) may explain its under-recognition in clinical 31 
practice. This study surveyed the opinions of health professionals (HP) on clinical indicators 32 
of DAM and barriers impeding routine nutritional screening in children.  33 
Methods: Web-based questionnaire survey (April 2013 - August 2015) in Australia, Belgium, 34 
Israel, Spain, The Netherlands, Turkey and UK.  35 
Results: There were 937 questionnaires returned via local professional associations, of which 36 
693 respondents fulfilled the inclusion criteria and were included in the final analysis; 315 37 
pediatric gastroenterologists and 378 pediatric dieticians. The most important clinical 38 
indicators of DAM were ongoing weight loss (80.4%), increased energy/nutrient losses 39 
(73.0%), suboptimal energy/macronutrient intake (68.6%), a high nutritional risk condition 40 
(67.2%) and increased energy/nutrient requirements (66.2%). These findings were consistent 41 
across countries and professions. The most common approach to screen for DAM was 42 
assessment of weight changes (85%), followed by the usage of growth charts (77-80%). 43 
Common perceived barriers for routine nutritional screening/assessment were low staff 44 
awareness (47.5%), no local policy or guidelines (33.4%) and lack of time to screen (33.4%).   45 
Conclusions: HP who routinely assess and treat children with DAM identified ongoing 46 
weight loss, increased losses, increased requirements, low intake and high nutritional risk 47 
conditions as the most important clinical indicators of DAM. These clinical indicators should 48 
now serve as a basis to form clinical-based criteria for the identification of DAM in routine 49 
clinical practice. Low awareness, lack of guidelines or local policy and lack of resources were 50 
the most important barriers of routine screening.   51 
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Introduction 52 
Despite continuous efforts from health professional associations to increase nutrition 53 
awareness and to improve early detection and management, a decrease in the prevalence of 54 
disease associated malnutrition (DAM) in hospitalized children in developed countries, has 55 
not been observed over the last decade1. Although the reasons for lack of progression in this 56 
area remain elusive, it is believed that the absence of a clinically and universally accepted 57 
way to assess and screen DAM delays timely identification and treatment. It is also becoming 58 
more recognized that the WHO criteria for screening of acute and chronic malnutrition in 59 
communities of low-medium income countries, may be inappropriate for use in the context of 60 
DAM, where its etiology is multifactorial and complicated by the background illness. In 61 
health services of affluent countries, there is also increasing interest in the prevention of 62 
DAM. Early management of patients whose nutritional status deteriorates is of utmost 63 
importance in such settings. 64 
 Previous research proposed measurements and frameworks to define pediatric DAM; 65 
with some focusing on the measurable consequences of DAM on body size 2 and composition 66 
3. Likewise, others incorporated information on etiology, chronicity and the effect of 67 
inflammation and clinical outcomes 4. The extent to which such proposals have been 68 
integrated and apply in routine clinical practice remains unknown.  69 
 As evidence-based approaches or experts consensus do not often echo in clinical 70 
practice, an alternative to these approaches, is to survey the opinions and practices of health 71 
professionals (HP) who routinely identify and treat children with DAM. While such an 72 
approach may not be considered evidence-based, it is a pragmatic one and has clinical 73 
relevance. 74 
 The aims of this study were: 75 
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1. To survey the opinions of HP practitioners on clinical indicators of children who 76 
suffer or are at risk of DAM. 77 
2. To propose clinical measurements and indicators of DAM based on the preponderance 78 
of HP responses. 79 
3. To collect responders’ perceptions on barriers of routine nutritional screening. 80 
  81 
6 
 
Methods 82 
Survey population 83 
As the objective of this survey was to collect opinions of HP who are the most likely to be 84 
involved in nutritional care of pediatric patients, the survey targeted pediatric 85 
gastroenterologists and pediatric dietitians with practicing experience in pediatric nutrition 86 
care. Responders who did not meet these inclusion criteria were excluded. A questionnaire 87 
survey was developed and distributed via the local professional associations of the 88 
participating countries (Australia, Belgium, Israel, Spain, The Netherlands, Turkey and UK) 89 
using the SurveyMonkey® website. As there is no formal Belgian professional group for 90 
pediatric dieticians, no dieticians were included from this country. Two reminders were sent 91 
with a two-week interval to all participants. The survey was anonymous and a prize draw of 92 
£100 was used as an incentive. 93 
 94 
Survey design and data collection 95 
A draft questionnaire was collated by two experts in the field of pediatric malnutrition 96 
screening (KG, JH). The questionnaire included a total of 16 multiple-choice and open-ended 97 
questions to elicit additional responses. The questions were divided into three sections. The 98 
first section collected information about the responders and their area of practice. Responses 99 
on this section were used to filter out responders who did not meet the inclusion criteria 100 
described above. The second section questioned the degree of importance of various features 101 
as clinical indicators of DAM and nutritional risk. This section was split into three 102 
subsections, each listing the following indicators of DAM: a) anthropometry and body 103 
composition, b) dietary intake and requirements, and c) a miscellaneous group encompassing 104 
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features like inflammation, functional capacity and biomarkers of nutritional status. The third 105 
section focused on nutritional screening methods, causes and long-term consequences of 106 
DAM and main barriers perceived to routine evaluation of nutritional status. An English 107 
version of the survey is available in Supplementary file 1. 108 
 Face-validity and readability of the questionnaire were tested by dietitians and 109 
pediatric gastroenterologists at the Royal Hospital for Children in Glasgow. The original 110 
questionnaire developed in English was translated to five different languages (Dutch, French, 111 
Hebrew, Spanish and Turkish) and then translated back into English to avoid language bias. 112 
The questionnaire was sent out between April 2013 and August 2015. 113 
 114 
Statistical analysis 115 
Statistical analysis was performed using R 5. Differences in proportions between groups were 116 
analyzed using χ²-test or Fisher’s exact test. In reporting of categorical data, weighted analysis 117 
was applied in which each country received a weight of 1, regardless of the number of 118 
respondents of that country. This avoided bias due to different number of responders per 119 
country. A p-value of <0.050 was considered statistically significant.  120 
  121 
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Results 122 
Respondent characteristics and data cleaning 123 
From a total of 937 respondents, 693 (74.0%) were taken forward to the final analysis after 124 
data curation. As 109 (11.6%) respondents ( Australia: n=4, Israel: n=71, Spain: n=24 and 125 
Turkey: n=1, The Netherlands: n=2 and UK: n=7) did not indicate to have clinical experience 126 
in pediatric medicine; 12 (1.3%; Australia: n=1, Israel: n=1, UK: n=10) or had a different or 127 
undisclosed profession than medical doctors (MD) or dieticians (RD), their responses were 128 
removed. Another 123 (13.1%) respondents were filtered out as they were not pediatric 129 
gastroenterologists or disclosed no expertise in nutrition (Supplementary file 2). Using the 130 
weighed statistical analysis approach, cumulative responses for each question received a 131 
relative weight of 1.1 for Australia; 2.9 for Belgium; 0.8 for Israel; 0.7 for Spain; 1.4 for The 132 
Netherlands; 1.3 for Turkey and 0.6 for the UK.  133 
 Overall, 75.2% (521/693) of the respondents answered ≥95% of the questions in the 134 
questionnaire. None of the questions were systematically omitted by the respondents. An 135 
overview of the characteristics of the respondents by country is displayed in Table 1. 136 
Dieticians had significantly fewer years of clinical experience (p-values <0.010) than MDs in 137 
all countries, except for The Netherlands (p=0.379). A significantly (p<0.001) higher 138 
proportion of MD (62.7%) than RD (40.4%) worked in a tertiary setting. 139 
 140 
Clinical indicators of disease associated malnutrition 141 
Overall results 142 
The degree of importance of anthropometry and body composition measurements, dietary 143 
intake, nutritional requirements and other features, as clinical indicators of DAM and 144 
9 
 
nutritional risk, are presented per country in Figure 1 and per profession in Figure 2. No 145 
differences were found between weighted or unweighted statistical analysis. The top five 146 
clinical indicators of DAM  deemed  the most important, were ongoing weight loss (80.4% 147 
highly important), increased energy/nutrient losses (73.0% highly important), suboptimal 148 
energy/macronutrient intake (68.6% highly important), a history of high nutritional risk 149 
condition (67.2% highly important) and increased energy/nutrient requirements (66.2% highly 150 
important). These results were largely consistent between the two professions and among the 151 
different countries (Figures 1 and 2). Likewise, the three least important clinical indicators of 152 
DAM were low fat but normal lean stores (31.3% not or slightly important), low activity 153 
levels (16.6% not or slightly important) and the age of the patient (13.9% not or slightly 154 
important). Less agreement was found for the least important clinical indicators between the 155 
professional designation of responders and across countries (Figures 1 and 2). 156 
 157 
Anthropometric and body composition as clinical indicators of DAM  158 
On ranking the importance of anthropometry and body composition as clinical indicators of 159 
DAM risk in children (Panels A of Figures 1 and 2), the top three ranked responses were 160 
weight loss (80.4% highly important), a low BMI/weight-for-height measurement (47.3% 161 
highly important) and low fat and lean stores (42.6% highly important). Likewise, the least 162 
important indicator of DAM was low fat stores, in the presence of normal lean mass levels 163 
(31.3% not or slightly important). The distribution of responses varied across countries (p-164 
values <0.001) for all indicators and between RD and MD for ongoing weight loss (p<0.001) 165 
and low fat with normal lean body mass (p=0.025).  166 
Intake & requirements as clinical indicators of DAM 167 
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The importance the respondents attributed to various intake & requirement aspects as 168 
indicators of DAM is represented in Panels B of Figures 1 and 2. The three indicators of 169 
DAM that ranked the highest were increased energy/nutrient losses (73.0% highly important), 170 
suboptimal energy/macronutrient intake (68.6% highly important) and a history of high 171 
nutritional risk condition (67.2% highly important).  Suboptimal micronutrient intake ranked 172 
the least important (39.9% highly important). Responses varied (all p-values <0.050) for all 173 
indicators across countries and between RD and MD (except for altered requirements due to 174 
impaired nutrient metabolism: p=0.560).  175 
 176 
Other clinical indicators of DAM 177 
Panels C of Figures 1 and 2 display the importance of other features or measurements as 178 
clinical indicators of DAM in sick children. Abnormal blood markers indicating poor 179 
nutritional status was selected most frequently as a highly important indicator of DAM 180 
(49.6%). This was followed by prematurity (32.9% highly important) and the presence of 181 
systemic inflammatory response (24.9% highly important). Low activity (16.6% not or 182 
slightly important) was the least important indicator of DAM. No significant differences (all 183 
p-values >0.050) were found for all indicators between RD and MD (except for age of the 184 
child and prematurity: p<0.001), but differences (p-values <0.010) across countries were 185 
noted for all these indicators, except for the importance attributed to a child with low activity 186 
(p=0.128). 187 
 188 
Etiology and consequences of DAM 189 
From the four available options, suboptimal intake ranked the most important cause (44.7% of 190 
the responders) and inflammatory response the least important (42.8%) (Supplementary files 191 
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3A&B). Significant (p<0.001) differences in responses were observed across countries and 192 
professions, although results were more consistent with regard to suboptimal intake which 193 
ranked as the most important cause of DAM for all countries.  194 
 Considering the long-term consequences of DAM in sick children, increased 195 
complication rate (71.5%), poor growth (71.5%), poor cognitive development (34.9%), slower 196 
disease recovery (32.2%) and an impaired immune function (23.1%) were most commonly 197 
selected as the “top three” consequences of DAM (Supplementary files 3C&D). 198 
 199 
Assessment and screening of DAM in routine clinical practice 200 
A total of 588 (84.8%) HP responded to the question regarding screening and assessment of 201 
DAM in routine clinical practice (Figure 3). Of these, 7% did not routinely screen for 202 
malnutrition (most frequent in Australia (16%) and the least frequent (0%) in The 203 
Netherlands; difference across countries: p=0.012). The most common approach to screen for 204 
DAM was assessment of weight changes (85%), followed by the usage of growth charts (77-205 
80%; the latter one done by a higher proportion of MDs than RDs (p-values <0.050). Usage of 206 
nutritional screening tools was reported in 23% of responders (Belgium, the Netherlands and 207 
UK: 40-50%, other countries ≤15%, p<0.001). Differences were noted between the countries 208 
in the way DAM was screened in routine clinical practice (Figure 3). This was the case for all 209 
available options, except for plotting of anthropometry on growth charts and classification of 210 
DAM risk based on the underlying/chronic condition, which were consistent among countries. 211 
Assessment of dietary intake as a screening method of DAM was performed significantly 212 
(p<0.001) more often by RD (second most common approach) than MD (fifth most common 213 
approach). MD performed more frequently laboratory testing as compared to RD (p<0.001) to 214 
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screen for DAM. Functional tests (e.g. grip strength) or energy levels were assessed only by a 215 
minority of the respondents. 216 
 217 
Perceived barriers to the routine evaluation of DAM in clinical practice 218 
A minority of respondents (77/583, 13.2%) did not perceive barriers for routine evaluation of 219 
DAM in routine clinical practice (most frequently in the UK: 22.9%); although differences 220 
were found between countries (p=0.003). A detailed overview of barriers by country and by 221 
profession is presented in Table 2 and in Supplementary file 4 respectively. The three most 222 
commonly perceived barriers, were low staff awareness on the role of nutrition on patient care 223 
(47.5%), absence of local policy or guidelines to screen (33.4%) and lack of time to screen 224 
(33.4%) for DAM. Likewise, inadequate clinical management pathways to intervene on 225 
undernourished children (14.6%) and a lower priority recognized to nutritional care as 226 
opposed to other aspects of patients’ care (13.4%) were least frequently selected. Barriers of 227 
routine evaluation of DAM in clinical practice varied across countries (Table 2). MD were 228 
more likely to experience the aforementioned barriers than RD, except for a lack of screening 229 
method (p=0.075), inadequate management strategies to intervene (p=0.074) and a lack of 230 
importance attributed to nutrition compared to other aspects of patients’ care (p=0.148). In 231 
contrast, a lack of a local policy to screen for DAM was more frequently (p=0.010) reported 232 
as a barrier by RD (38.2%) than MD (28.2%). 233 
234 
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Discussion 235 
This study is the first to investigate the opinions and practices of an international cohort of HP 236 
on aspects pertinent to pediatric DAM. Ongoing weight loss, increased losses, increased 237 
requirements, low dietary intake and a high risk condition ranked as the most important 238 
clinical indicators of children with DAM. These top five clinical indicators of a child at risk 239 
of DAM were remarkably consistent across different countries. Evaluation of weight changes 240 
also featured as the most common approach to screen for DAM in routine clinical practice.  241 
Low staff awareness on the role of nutrition in patient care, lack of local policy or guidelines 242 
to screen for DAM and lack of time to screen were the most commonly reported barriers for 243 
routine nutritional screening. 244 
 DAM in children is the consequence of a complex interplay of various etiological 245 
factors, making it a condition that is difficult to evaluate with a single measurement or 246 
biomarker. While there is still debate about the optimal definition and measurement of DAM, 247 
and until evidence from intervention studies become available, these top five clinical 248 
indicators identified in this survey can serve as the basis to formulate universal, practice-249 
based, screening and assessment criteria for the identification of DAM in routine clinical 250 
practice. It is noteworthy, that similar indicators were proposed by a recent consensus 251 
statement published by the Academy of Nutrition and Dietetics and the American Society for 252 
Parenteral and Enteral Nutrition 6. A decline in weight velocity and unintentional weight loss, 253 
were highlighted as the most important indicators and measurements of DAM and were 254 
deemed more important than a static measurement of low BMI. Moreover, the importance 255 
that was attributed to weight loss and a decline in weight velocity was consistent between 256 
countries and type of HP and it suggests that weight loss has a stronger predictive value, than 257 
low BMI alone, to indicate children at risk of DAM. While the exact cutoffs of growth 258 
faltering are still under debate, a sustained unintentional weight loss or poor weight gain 259 
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should be a “never event” for children with illness 7. Low intake, increased losses and 260 
increased requirements were selected as other important indicators of DAM in this survey and 261 
these findings are in agreement with aspects of the etiological definition of DAM recently 262 
proposed by Mehta et al 4. Assessing the origins of DAM is imperative to implement 263 
appropriate nutritional interventions and distinguish poor linear growth due to genetic 264 
disorders, from insufficient caloric intake, the independent effect of inflammatory response or 265 
an interaction of all. Against our expectations and consensus recommendations and 266 
guidelines, little importance has been placed by the responders to the assessment of body 267 
composition as an indicator of DAM. There is good research evidence to suggest that children 268 
with chronic inflammatory conditions have altered body composition characteristics 8 but as it 269 
is yet unclear what the implications of this are, with regard to patients outcomes and direct 270 
clinical management, it is not surprising that clinical practitioners do not value its importance 271 
in routine practice. Availability of equipment to assess body composition could also play a 272 
role, which is something we did not assess in our survey. Incorporation of inflammatory 273 
process in the assessment framework of DAM is currently debated 9. In this regard, only a 274 
quarter of our responders attributed high importance to the role of inflammation as indicator 275 
and measurement of DAM; a finding which challenges the proposal of Mehta based on the 276 
available peer-reviewed literature 4. This is likely to suggest a lack of translation of research 277 
evidence to bedside practice or that HP do not value the effect of inflammatory response on 278 
DAM as important, particularly when the latter is often difficult to ascertain or measure. It 279 
might also be that the effect of inflammation on DAM overlaps with the effect of presence of 280 
a high nutritional risk condition that our participants valued among the top indicators of 281 
DAM; although not all conditions which lead to malnutrition are associated with 282 
inflammation.  283 
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 A quarter of the respondents used validated nutritional screening tools as a method of 284 
choice to screen for DAM, even though their use has been supported by several health 285 
professional bodies 4, 10, 11. Neither a large European study nor a systematic review of other, 286 
smaller studies provided sufficient evidence to recommend one screening tool over another 287 
which may explain these findings 12, 13.  288 
 Low staff awareness on nutrition, lack of time and lack of local guidelines for nutrition 289 
screening were the most important barriers to the routine evaluation of DAM. These results 290 
are very similar to the findings of a Belgian survey in secondary care hospitals 14. The 291 
differences across countries in the perceived barriers of routine evaluation of DAM may 292 
reflect variation in health practices, resources and agreed health priorities across countries. 293 
For example, a lack of personnel and/or dieticians was more of an issue in Spain, Turkey, 294 
Belgium and the UK, whereas inadequate equipment was of concern mainly in Spain and 295 
Israel. Whether this is true, or rather a perception is impossible to address and it is beyond the 296 
scope of this survey. Jointly these findings prove that even though the scientific community 297 
has raised awareness on pediatric DAM, more evidence is required to prove the clinical 298 
benefit of nutritional screening in clinical practice. More and better quality evidence, deriving 299 
from intervention studies, are needed to demonstrate that implementation of nutritional 300 
screening at hospital routine can improve patients’ outcomes and reduce health expenditure. 301 
 The major strengths of this study are the large number and international representation 302 
of respondents and the fact that we only surveyed participants with clinical experience in 303 
pediatric nutrition care. Even though the survey was distributed via local professional 304 
associations of participating countries, we were unable to ensure the representation of our 305 
population. Although the number of respondents was unevenly distributed over the different 306 
countries, we overcame this potential limitation by performing weighted analyses. Lastly, 307 
while this study helps us in identifying the most important clinical indicators of DAM, it does 308 
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not answer the question which screening or assessment thresholds should be applied for 309 
further nutritional assessment or intervention. This is an aspect which needs to be explored in 310 
future research. As this survey was conducted in developed countries, it may not represent the 311 
HP opinions of DAM in low-medium income countries.  312 
Conclusion  313 
This survey identified ongoing weight loss, increased nutrient losses, increased requirements, 314 
low intake and a high risk condition as the most valued clinical indicators of DAM by HP 315 
who routinely assess and treat children with DAM. These indicators should serve as a basis to 316 
form consensus, clinical-based criteria for screening and assessment of DAM. Low 317 
awareness, lack of guidelines or local policy and lack of resources were the most important 318 
barriers of routine screening. More and better quality of evidence is required to inform the 319 
benefit of nutritional screening and overcome barriers in its routine implementation.  320 
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Figure 1. Importance of various clinical indicators of disease associated malnutrition 379 
across different countries 380 
N/A: not answered 381 
 382 
Figure 2. Importance of various clinical indicators of disease associated malnutrition 383 
across different professions 384 
N/A: not answered; RD: dieticians; MD: medical doctor 385 
 386 
Figure 3. Assessment of disease associated malnutrition and nutritional risk in clinical 387 
practice 388 
N/A: not answered; RD: dieticians; MD: medical doctor 389 
 390 
Table 1. Respondent characteristics 391 
 392 
Table 2. Barriers to the routine evaluation of nutritional status by country 393 
 394 
Table 1. Respondent characteristics 
 Total 
n 
Australia 
n (%) 
Belgium 
n (%) 
Israel 
n (%) 
The Netherlands 
n (%) 
Spain 
n (%) 
Turkey 
n (%) 
UK 
n (%) 
p-value 
Profession         <0.001 
   MD 315 9 (2.9) 34 (10.8) 17 (5.4) 45 (14.3) 119 (37.8) 57 (18.1) 34 (10.8)  
   RD 378 80 (21.2) - 109 (28.8) 28 (7.4) 20 (5.3) 22 (5.8) 119 (31.5)  
Paediatric experience (years)* 693 6.0 (1-40) 13.0 (3-41) 7.0 (1-46) 15 (1-40) 12.0 (1-45) 14.0 (1-45) 11.0 (1-35) <0.001 
Health care setting** 690         
   General Hospital 460 29 (12.6) 18 (7.8) 40 (17.4) 28 (12.2) 46 (20.0) 15 (6.5) 54 (23.5) 0.026 
   Specialist Hospital 349 51 (14.6) 19 (5.4) 28 (8.0) 44 (12.6) 76 (21.8) 58 (16.6) 73 (20.9) <0.001 
   Community 126 10 (7.9) 0 (0) 79 (62.7) 0 (0) 7 (5.6) 2 (1.6) 28 (22.2) <0.001 
   Private care 73 3 (4.1) 0 (0) 35 (47.9) 0 (0) 29 (39.7) 4 (5.5) 2 (2.7) <0.001 
   Primary care 20 3 (15.0) 2 (10.0) 5 (25.0) 0 (0) 2 (10.0) 0 (0) 8 (40.0) 0.116 
   N/A 3 0 0 0 1 (33.3) 0 1 (33.3) 1 (33.3)  
Highest educational degree 669        <0.001 
   BSc 240 53 (22.1) 0 (0) 64 (26.7) 19 (7.9) 1 (0.4) 4 (1.7) 99 (41.3)  
   MSc 109 23 (21.1) 1 (0.9) 41 (37.6) 2 (1.8) 24 (22.0) 0 (0) 18 (16.5)  
   MD 273 8 (2.9) 26 (9.5) 12 (4.4) 25 (9.2) 109 (39.9) 62 (22.7) 31 (11.4)  
   PhD 47 4 (8.5) 7 (14.9) 4 (8.5) 22 (46.8) 4 (8.5) 1 (2.1) 5 (10.6)  
   N/A 24 1 (4.2) 0 (0) 5 (20.8) 5 (20.8) 1 (4.2) 12 (50.0) 0 (0)  
*median (range); **multiple answers possible per respondent; N/A: not answered; BSc: Bachelor in Science; MSc: Master in Science; MD: 
medical doctor; RD: Registered dietitians; PhD: doctor of philosophy 
 
Table 2. Barriers to the routine evaluation of nutritional status by country 
 Total 
n (%) 
Australia 
 n (%) 
Belgium 
n (%) 
Israel 
n (%) 
Netherlands 
n (%) 
Spain 
n (%) 
Turkey 
n (%) 
UK 
n (%) 
p-value 
No barriers 77 (13.2) 7 (9.5) 5 (17.2) 11 (12.1) 10 (16.4) 7 (5.8) 7 (9.2) 30 (22.9) 0.003 
Low staff awareness 277 (47.5) 39 (52.7) 6 (20.7) 28 (30.8) 22 (36.1) 87 (71.9) 47 (61.8) 48 (36.6) <0.001 
No local policy or guidelines 195 (33.4) 39 (52.7) 10 (34.5) 41 (45.1) 9 (14.8) 39 (32.2) 26 (34.2) 31 (23.7) <0.001 
Lack of time 195 (33.4) 19 (25.7) 12 (41.4) 29 (31.9) 12 (19.7) 48 (39.7) 37 (48.7) 38 (29.0) 0.004 
Not many dieticians to intervene 191 (32.8) 13 (17.6) 8 (27.6) 12 (13.2) 13 (21.3) 75 (62.0) 39 (51.3) 31 (23.7) <0.001 
No training 181 (31.0) 21 (28.4) 14 (48.3) 30 (33.0) 15 (24.6) 54 (44.6) 22 (28.9) 25 (19.1) <0.001 
No method in place for 
screening 
137 (23.5) 32 (43.2) 4 (13.8) 27 (29.7) 4 (6.6) 47 (38.8) 4 (5.3) 19 (14.5) <0.001 
Lack of staff 137 (23.5) 18 (24.3) 4 (13.8) 16 (17.6) 8 (13.1) 48 (39.7) 17 (22.4) 26 (19.8) <0.001 
Lack of nutrition support teams 128 (22.0) 19 (25.7) 9 (31.0) 14 (15.4) 7 (11.5) 33 (27.3) 22 (28.9) 24 (18.3) 0.038 
Inadequate equipment 125 (21.4) 15 (20.3) 3 (10.3) 25 (27.5) 3 (4.9) 50 (41.3) 11 (14.5) 18 (13.7) <0.001 
Inadequate strategies to 
intervene 
85 (14.6) 6 (8.1) 0 (0) 15 (16.5) 3 (4.9) 26 (21.5) 22 (28.9) 13 (9.9) <0.001 
Nutrition less important than 
other aspects of patient care 
78 (13.4) 5 (6.8) 6 (20.7) 4 (4.4) 23 (37.7) 6 (5.0) 18 (23.7) 16 (12.2) <0.001 
Not answered: n= 110 
 



